CAR T-Cell Therapy for R/R Multiple Myeloma: Sharing Expert Insights to Advance Outcomes

Do you know the eligibility criteria for CAR T-cell therapy in relapsed/refractory (R/R) multiple myeloma (MM); did you know that there is no age limit for patients? Credit available for this activity expires: 4/26/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/972593?src=mkm_podcast_addon_972593